tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

10x Genomics price target lowered to $19 from $21 at Barclays

Barclays analyst Luke Sergott lowered the firm’s price target on 10x Genomics (TXG) to $19 from $21 and keeps an Overweight rating on the shares. The company reported a “tough” quarter driven by a commercial reorganization and soft genomics capex environment, the analyst tells investors in a research note. The firm believes this is the trough of the demand environment and says the reorg should start to kick in modestly as genomics capex demand starts to improve.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1